Because of this additional action, Zepbound is known as a dual-action GLP-1 and GIP receptor agonist
It works by mimicking the actions of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1)
As of October 2024, a handful of these products are in late-phase clinical trials, with active ingredients such as retatrutide, survodutide and ecnoglutide, and more than 18 other drug candidates are in earlier stages of development
Once you begin treatment, check your injection each time before use for visible changes: cloudiness, discoloration, or precipitate particles indicate the medication should not be used
Fortunately, with a little preparation, you can easily manage your GLP-1 therapy while you're on the go